These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25443575)

  • 21. [Stroke in chronic renal failure].
    Bereczki D
    Orv Hetil; 2008 Apr; 149(15):691-6. PubMed ID: 18387873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Ahmad Y; Lip GY
    Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic drug treatment of pediatric patients with ischemic stroke.
    Nowak-Göttl U; Sträeter R; Sébire G; Kirkham F
    Paediatr Drugs; 2003; 5(3):167-75. PubMed ID: 12608881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombolysis and hyperacute reperfusion therapy for stroke in renal patients.
    Hirano T
    Contrib Nephrol; 2013; 179():110-8. PubMed ID: 23652454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statin use and functional outcome after tissue plasminogen activator treatment in acute ischaemic stroke.
    Miedema I; Uyttenboogaart M; Koopman K; De Keyser J; Luijckx GJ
    Cerebrovasc Dis; 2010 Feb; 29(3):263-7. PubMed ID: 20090317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?
    Roldán V; Marín F; Manzano-Fernandez S; Fernández H; Gallego P; Valdés M; Vicente V; Lip GY
    Thromb Haemost; 2013 May; 109(5):956-60. PubMed ID: 23572113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiological aspects of stroke prevention.
    Fisher M; McAllister M
    Circ J; 2015; 79(2):271-7. PubMed ID: 25744741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emergency department: first line of defense in preventing secondary stroke.
    Ovbiagele B
    Acad Emerg Med; 2006 Feb; 13(2):215-22. PubMed ID: 16436789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences.
    Fisher M; Folland E
    Am J Ther; 2008; 15(2):137-49. PubMed ID: 18356634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prevention of stroke].
    Endres M
    Drug Res (Stuttg); 2013 Nov; 63 Suppl 1():S14-5. PubMed ID: 24242030
    [No Abstract]   [Full Text] [Related]  

  • 32. [Secondary prevention of ischemic non cardioembolic stroke].
    Armario P; Pinto X; Soler C; Cardona P
    Clin Investig Arterioscler; 2015; 27(6):287-300. PubMed ID: 25771074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stroke in dialysis and chronic kidney disease.
    Power A
    Blood Purif; 2013; 36(3-4):179-83. PubMed ID: 24496188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of ischemic stroke after an acute myocardial infarction in patients with decreased renal function.
    Jakobsson S; Graipe A; Huber D; Björklund F; Mooe T
    Cerebrovasc Dis; 2014; 37(6):460-9. PubMed ID: 25073588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A risk factors for stroke in the patients with chronic kidney disease].
    Kes P; Basić-Kes V; Basić-Jukić N; Jurić I
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():67-77. PubMed ID: 23120820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low glomerular filtration rate increases hemorrhagic transformation in acute ischemic stroke.
    Lee JG; Lee KB; Jang IM; Roh H; Ahn MY; Woo HY; Hwang HW
    Cerebrovasc Dis; 2013; 35(1):53-9. PubMed ID: 23428997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association?
    Athyros VG; Tziomalos K; Karagiannis A; Wierzbicki AS; Mikhailidis DP
    Curr Opin Cardiol; 2010 Jul; 25(4):406-10. PubMed ID: 20375883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospitalized hemorrhagic stroke patients with renal insufficiency: clinical characteristics, care patterns, and outcomes.
    Ovbiagele B; Schwamm LH; Smith EE; Grau-Sepulveda MV; Saver JL; Bhatt DL; Hernandez AF; Peterson ED; Fonarow GC
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2265-73. PubMed ID: 25158677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment].
    García Escrivà A; López Hernández N; Hernández Lorido R; Oliver Navarrete C; Bustos S; Carneado Ruiz J; Gracia Fleta F; Moltó Jordá JM
    Rev Neurol; 2004 Mar 1-15; 38(5):401-5. PubMed ID: 15029514
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticoagulation in atrial fibrillation and co-existent chronic kidney disease: efficacy versus safety.
    Salim I; Al Suwaidi J; Ghadban W; Salam AM
    Expert Opin Drug Saf; 2013 Jan; 12(1):53-63. PubMed ID: 23095103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.